REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

The Revert partners finally met in Rome in November 2022 for strengthening their collaboration spirit

In November 28-29 2022 the REVERT partners met in Rome in the San Raffaele Research Center headquarters, leader of the REVERT project.

During these two days the project organised different specific meetings in order to deal with important topics.

In the first day the Executive board meeting discussed about GDPR issues, particularly  regarding the data of patients included in the clinical trial of the project and the compliance with the provisions of the Regulation.

In the second day, during the General Assembly, each Work package leader described the state of play of the WP leaded and the actions to be taken in the following months.

Finally, partners agreed to meet again in person in Spain in February 2022 in the following consortium meeting.

Stay tuned!


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848098”.

Copyright 2020 REVERT ©  All Rights Reserved